The mechanism of exogenous adiponectin in the prevention of no-reflow phenomenon in type 2 diabetic patients with acute myocardial infarction during PCI treatment.
- DOI
- 10.26355/eurrev_201804_14751
- Published
- 2018 Apr
- Container
- European review for medical and pharmacological sciences
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
serious concern Score 8/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- serious concernRetraction Watch retraction: 1 retraction notice matched this DOI.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.26355/eurrev_201804_14751,
title = {The mechanism of exogenous adiponectin in the prevention of no-reflow phenomenon in type 2 diabetic patients with acute myocardial infarction during PCI treatment.},
author = {Zhang CJ and Deng YZ and Lei YH and Zhao JB and Wei W and Li YH},
year = {2018},
journal = {European review for medical and pharmacological sciences},
doi = {10.26355/eurrev_201804_14751},
url = {https://doi.org/10.26355/eurrev_201804_14751}
}RIS
TY - JOUR TI - The mechanism of exogenous adiponectin in the prevention of no-reflow phenomenon in type 2 diabetic patients with acute myocardial infarction during PCI treatment. AU - Zhang CJ AU - Deng YZ AU - Lei YH AU - Zhao JB AU - Wei W AU - Li YH PY - 2018 JO - European review for medical and pharmacological sciences DO - 10.26355/eurrev_201804_14751 UR - https://doi.org/10.26355/eurrev_201804_14751 ER -
APA
CJ, Z., YZ, D., YH, L., JB, Z., W, W., & YH, L. (2018). The mechanism of exogenous adiponectin in the prevention of no-reflow phenomenon in type 2 diabetic patients with acute myocardial infarction during PCI treatment.. European review for medical and pharmacological sciences. https://doi.org/10.26355/eurrev_201804_14751
Source records
- pubmed · retrieved 2026-09-25T10:19:13.653Z